Tag: Samsung Biologics

Samsung Biologics reports second quarter 2025 financial results

Recorded Q2'25 consolidated revenue of KRW 1,289.9 billionRecorded Q2'25 consolidated operating profit of KRW 475.6 billionSolid momentum sustained through capacity ramp-up and stable project...

Samsung Biologics launches drug screening services, Samsung Organoids

Samsung Organoids to provide data-driven analysis of candidate moleculesSamsung Biologics expands service scope to include preclinical researchINCHEON, South Korea, June 15, 2025 /PRNewswire/ --...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsSamsung Biologics

Director/PDMR Shareholding

Aptean Appoints Yama Habibzai as Chief Marketing Officer

Taboola Announces Inclusion in Russell 3000® and 2000® Index

Tag: Samsung Biologics

Samsung Biologics reports second quarter 2025 financial results

Samsung Biologics launches drug screening services, Samsung Organoids

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us